GST Reforms on Medicines, Medical Devices, and Insurance

New GST rates effective September 22, 2025, have ushered in dramatic reductions across healthcare essentials. Most medicines now attract only 5% GST (down from 12%), with life-saving drugs (36 categories) declared entirely GST-free. Critical treatments for cancer, rare diseases, and severe cardiovascular conditions are now more affordable.

The reforms mandate pharmaceutical manufacturers to lower MRPs and pass on benefits to patients. Furthermore, all health and life insurance premiums are exempt from GST, immediately reducing costs and making insurance more accessible, especially for middle-income households coping with healthcare inflation.

Latest news

IAS Dr Balkar Singh Takes Charge as CEO of Greater Noida Authority

IAS officer Dr Balkar Singh has been appointed Chief Executive Officer (CEO) of the Greater Noida Authority, along with...

Kishore Seshagiri Joins Vanguard India as Chief Technology Officer

Vanguard India has appointed Kishore Seshagiri as its Chief Technology Officer (CTO). In his new role, he will lead...

Arna Softech Names Chaitanya Mishra as Its New Chief Revenue Officer

Arna Softech has appointed Chaitanya Mishra as its Chief Revenue Officer (CRO). In his new role, he will lead...

IPS Officer Mahesh Bhagwat Takes Charge as Hyderabad Police Commissioner

IPS officer Mahesh Bhagwat has been appointed as the new Commissioner of Police, Hyderabad. His appointment marks a key...
spot_img

You might also likeRELATED
Recommended to you

spot_img